Wong V.W.-S.Chan W.-K.Chitturi S.Chawla Y.Dan Y.Y.Duseja A.Fan J.Goh K.-L.Hamaguchi M.Hashimoto E.Kim S.U.Lesmana L.A.Lin Y.-C.CHUN-JEN LIUYEN-HSUAN NISollano J.Wong S.K.-H.Wong G.L.-H.Chan H.L.-Y.Farrell G.2022-01-242022-01-2420180815-9319https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039442844&doi=10.1111%2fjgh.13857&partnerID=40&md5=ca74e981888b85cfd76a2789dc155c6ehttps://scholars.lib.ntu.edu.tw/handle/123456789/593065[SDGs]SDG3adiponectin; cytokeratin 18; ghrelin; leptin; resistin; retinol binding protein 4; alcohol consumption; anamnesis; blood analysis; clinical assessment; consensus development; decompensated liver cirrhosis; e-mail; echography; fatty liver; human; incidence; insulin resistance; liver biopsy; liver cell carcinoma; liver cirrhosis; liver fibrosis; liver histology; medical history; nonalcoholic fatty liver; nuclear magnetic resonance imaging; overnutrition; physical examination; practice guideline; prevalence; priority journal; Review; screening; thrombocyte count; transient elastography; adolescent; Asia; child; gastroenterology; nonalcoholic fatty liver; organization and management; Pacific islands; risk assessment; risk factor; virus hepatitis; Adolescent; Asia; Child; Gastroenterology; Hepatitis, Viral, Human; Humans; Non-alcoholic Fatty Liver Disease; Pacific Islands; Practice Guidelines as Topic; Prevalence; Risk Assessment; Risk Factors; Systematic Reviews as TopicAsia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessmentreview10.1111/jgh.13857286707122-s2.0-85039442844